20 of the respondents in November 2010. MS market dynamics will also be measured in upcoming syndicated reports including TreatmentTrends®: Multiple Sclerosis
and ChartTrends®: Multiple Sclerosis
. BioTrends also recently published the first wave of LaunchTrends®: Gilenya
, a report series tracking trial, uptake, and perceptions of Novartis' Gilenya, at one, three and six months post launch. The next wave will be published in February 2011.
About LaunchTrendsLaunchTrends assesses trial and use of new products, obstacles to use, reasons to use, typical patient types, line of therapy, product perceptions, promotional efforts/messages and product satisfaction.
About BioTrends Research Group, Inc.BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or www.bio-trends.com.
About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand, or product names contained in this document may be trademarks of their respective holders.For more information, contact:BioTrends Research Group, Inc.Sharon Funk404firstname.lastname@example.org Decision Resources, Inc.Christopher Comfort781-993-2597 email@example.com
Page: 1 2 3 Related biology technology :1
|SOURCE BioTrends Research Group, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments2
. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix3
. [video] Wall St. Networks 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: IMMU, KYUS4
. [video] Wall St. Networks 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR, BHRT, AGO5
. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights6
. TorreyPines Therapeutics Reports Third Quarter 2008 Results and Recent Accomplishments7
. New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinsons Disease Drug Development8
. Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium9
. American Oriental Bioengineering Comments on Recent Property Purchase10
. Recent Advances in Organic Chemistry Using Real-Time In Situ FTIR11
. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading